GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (OTCPK:BPMUF) » Definitions » Deferred Policy Acquisition Costs

BPMUF (Basilea Pharmaceutica) Deferred Policy Acquisition Costs


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Basilea Pharmaceutica Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 167b, Allschwil, CHE, 4123
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.